Merck KGaA to tap Oschmann as new CEO
Merck KGaA is the latest company to join Big Pharma's recent round of executive musical chairs. The German drugmaker is promoting deputy chief executive...
Bangalore – The Silicon City, is now the Pharma City
"There is no second thought on the capability of the Indian pharma industry and Bangalore is gearing up to play its role as a...
CDSCO Ahmedabad becomes first ISO certified zonal regulatory office in India
In a strategic development, the zonal office of Central Drugs Standard Control Organisation (CDSCO) Ahmedabad was recognised with the certification of ISO 9001:2008 standards...
Omega-3 fatty acids and vitamin D may control brain serotonin
Although essential marine omega-3 fatty acids and vitamin D have been shown to improve cognitive function and behavior in the context of certain brain...
GSK’s new chairman Hampton to take charge in May
GlaxoSmithKline said on Thursday that its chairman-designate Philip Hampton would take charge of Britain's biggest drugmaker from May 7, an earlier transition than initially...
Graphene shows potential as novel anti-cancer therapeutic strategy
University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells. This new development opens up...
New test to predict the effectiveness of cancer vaccines
Cancer vaccines are designed to turn the body's own immune system specifically against tumor cells. Particularly promising are vaccines that are directed against so-called...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...